Avecho Biotechnology Ltd (AVE) — Cash Flow Quality Index
Avecho Biotechnology Ltd (AVE) has a Cash Flow Quality Index of 1.14x as of June 2019. Operating cash flow of AU$2.62 Million exceeds net income of AU$2.31 Million, indicating high earnings quality where cash backs reported profits. Explore Avecho Biotechnology Ltd cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Avecho Biotechnology Ltd Cash Flow Quality Index (1993–2019)
Historical Cash Flow Quality Index for Avecho Biotechnology Ltd across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check AVE cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Avecho Biotechnology Ltd (1993–2019)
Year-by-year earnings quality comparison for Avecho Biotechnology Ltd. For live market cap and the full company financial profile, see AVE company net worth.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 1.40x | AU$1.19 Million | AU$849.96K | ▲ +116.6% |
| 2011 | -8.40x | AU$-9.29 Million | AU$1.11 Million | ▼ -1152.6% |
| 1999 | -0.67x | AU$-337.79K | AU$503.57K | ▼ -724.9% |
| 1995 | -0.08x | AU$-1.43 Million | AU$17.62 Million | ▼ -388.5% |
| 1993 | 0.03x | AU$23.00K | AU$816.00K | — |